{
  "hypothesis": "h236",
  "title": "High-Indication Drug Ranking Gap Analysis",
  "key_finding": "kNN collaborative filtering favors FOCUSED drugs over BROAD-SPECTRUM drugs",
  "example": {
    "metformin": {
      "gt_diseases": 123,
      "missing_from_t2d_top30": true,
      "reason": "Spread across diverse diseases; diluted signal for any specific disease"
    },
    "empagliflozin": {
      "gt_diseases": 9,
      "in_t2d_top30": true,
      "reason": "Focused on metabolic diseases; concentrated signal"
    }
  },
  "implication": "This is a design property, not a bug. kNN is good for predicting what a disease IS LIKE, but misses broadly-applicable drugs.",
  "recommendation": "Could add indication-count-based boosting but may increase false positives"
}